| UniProt ID | PTCD3_HUMAN | |
|---|---|---|
| UniProt AC | Q96EY7 | |
| Protein Name | Pentatricopeptide repeat domain-containing protein 3, mitochondrial | |
| Gene Name | PTCD3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 689 | |
| Subcellular Localization | Mitochondrion . | |
| Protein Description | Mitochondrial RNA-binding protein that has a role in mitochondrial translation.. | |
| Protein Sequence | MAVVSAVRWLGLRSRLGQPLTGRRAGLCEQARSCRFYSGSATLSKVEGTDVTGIEEVVIPKKKTWDKVAVLQALASTVNRDTTAVPYVFQDDPYLMPASSLESRSFLLAKKSGENVAKFIINSYPKYFQKDIAEPHIPCLMPEYFEPQIKDISEAALKERIELRKVKASVDMFDQLLQAGTTVSLETTNSLLDLLCYYGDQEPSTDYHFQQTGQSEALEEENDETSRRKAGHQFGVTWRAKNNAERIFSLMPEKNEHSYCTMIRGMVKHRAYEQALNLYTELLNNRLHADVYTFNALIEATVCAINEKFEEKWSKILELLRHMVAQKVKPNLQTFNTILKCLRRFHVFARSPALQVLREMKAIGIEPSLATYHHIIRLFDQPGDPLKRSSFIIYDIMNELMGKRFSPKDPDDDKFFQSAMSICSSLRDLELAYQVHGLLKTGDNWKFIGPDQHRNFYYSKFFDLICLMEQIDVTLKWYEDLIPSAYFPHSQTMIHLLQALDVANRLEVIPKIWKDSKEYGHTFRSDLREEILMLMARDKHPPELQVAFADCAADIKSAYESQPIRQTAQDWPATSLNCIAILFLRAGRTQEAWKMLGLFRKHNKIPRSELLNELMDSAKVSNSPSQAIEVVELASAFSLPICEGLTQRVMSDFAINQEQKEALSNLTALTSDSDTDSSSDSDSDTSEGK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Phosphorylation | ---MAVVSAVRWLGL ---CCHHHHHHHHHH | 17.91 | - | |
| 14 | Phosphorylation | VRWLGLRSRLGQPLT HHHHHHHHHCCCCCC | 36.58 | 24043423 | |
| 37 | Phosphorylation | QARSCRFYSGSATLS HHHCCCEEECCEEEE | 7.86 | 21406692 | |
| 38 | Phosphorylation | ARSCRFYSGSATLSK HHCCCEEECCEEEEE | 24.45 | 21406692 | |
| 40 | Phosphorylation | SCRFYSGSATLSKVE CCCEEECCEEEEEEE | 16.49 | 21406692 | |
| 42 | Phosphorylation | RFYSGSATLSKVEGT CEEECCEEEEEEECC | 33.01 | 21406692 | |
| 44 | Phosphorylation | YSGSATLSKVEGTDV EECCEEEEEEECCCC | 30.24 | 21406692 | |
| 45 | Ubiquitination | SGSATLSKVEGTDVT ECCEEEEEEECCCCC | 47.63 | 23503661 | |
| 61 | Ubiquitination | IEEVVIPKKKTWDKV CEEEEECCCCCHHHH | 56.64 | 23503661 | |
| 62 | Ubiquitination | EEVVIPKKKTWDKVA EEEEECCCCCHHHHH | 50.51 | 22817900 | |
| 63 | Ubiquitination | EVVIPKKKTWDKVAV EEEECCCCCHHHHHH | 62.06 | 22817900 | |
| 67 (in isoform 1) | Ubiquitination | - | 24.53 | 21890473 | |
| 67 | Ubiquitination | PKKKTWDKVAVLQAL CCCCCHHHHHHHHHH | 24.53 | 21890473 | |
| 76 | Phosphorylation | AVLQALASTVNRDTT HHHHHHHHHCCCCCC | 33.47 | 22210691 | |
| 77 | Phosphorylation | VLQALASTVNRDTTA HHHHHHHHCCCCCCC | 19.05 | 22210691 | |
| 94 | Phosphorylation | YVFQDDPYLMPASSL EEECCCCCCEECCHH | 23.72 | 20068231 | |
| 99 | Phosphorylation | DPYLMPASSLESRSF CCCCEECCHHHHHHH | 29.59 | 20068231 | |
| 100 | Phosphorylation | PYLMPASSLESRSFL CCCEECCHHHHHHHH | 37.96 | 20068231 | |
| 103 | Phosphorylation | MPASSLESRSFLLAK EECCHHHHHHHHHHH | 38.22 | 20068231 | |
| 110 | 2-Hydroxyisobutyrylation | SRSFLLAKKSGENVA HHHHHHHHHCCCCHH | 47.65 | - | |
| 118 | Acetylation | KSGENVAKFIINSYP HCCCCHHHHHHHCCH | 32.58 | 26051181 | |
| 123 | Phosphorylation | VAKFIINSYPKYFQK HHHHHHHCCHHHHCC | 32.19 | 24719451 | |
| 124 | Phosphorylation | AKFIINSYPKYFQKD HHHHHHCCHHHHCCC | 10.15 | 29083192 | |
| 126 (in isoform 1) | Ubiquitination | - | 50.92 | 21890473 | |
| 126 | Malonylation | FIINSYPKYFQKDIA HHHHCCHHHHCCCCC | 50.92 | 26320211 | |
| 126 | Acetylation | FIINSYPKYFQKDIA HHHHCCHHHHCCCCC | 50.92 | 19608861 | |
| 126 | Ubiquitination | FIINSYPKYFQKDIA HHHHCCHHHHCCCCC | 50.92 | 21890473 | |
| 127 | Phosphorylation | IINSYPKYFQKDIAE HHHCCHHHHCCCCCC | 13.51 | 29083192 | |
| 130 | Ubiquitination | SYPKYFQKDIAEPHI CCHHHHCCCCCCCCC | 41.00 | 22817900 | |
| 139 | Glutathionylation | IAEPHIPCLMPEYFE CCCCCCCCCCHHHCC | 5.13 | 22555962 | |
| 144 | Phosphorylation | IPCLMPEYFEPQIKD CCCCCHHHCCHHHCC | 13.84 | 26356563 | |
| 158 | Ubiquitination | DISEAALKERIELRK CCHHHHHHHHHHHHH | 39.97 | 23503661 | |
| 259 | Phosphorylation | PEKNEHSYCTMIRGM CCCCCCCCHHHHHHH | 8.21 | 28674151 | |
| 261 | Phosphorylation | KNEHSYCTMIRGMVK CCCCCCHHHHHHHHH | 13.85 | 28674151 | |
| 279 | Phosphorylation | YEQALNLYTELLNNR HHHHHHHHHHHHHCC | 9.33 | - | |
| 280 | Phosphorylation | EQALNLYTELLNNRL HHHHHHHHHHHHCCC | 24.27 | - | |
| 334 | Phosphorylation | KVKPNLQTFNTILKC HCCCCHHHHHHHHHH | 23.24 | 28842319 | |
| 337 | Phosphorylation | PNLQTFNTILKCLRR CCHHHHHHHHHHHHH | 24.40 | 28842319 | |
| 372 | Phosphorylation | IEPSLATYHHIIRLF CCCCHHHHHHHHHHH | 5.94 | - | |
| 387 | 2-Hydroxyisobutyrylation | DQPGDPLKRSSFIIY CCCCCCCCCCHHHHH | 56.47 | - | |
| 387 | Ubiquitination | DQPGDPLKRSSFIIY CCCCCCCCCCHHHHH | 56.47 | 24816145 | |
| 387 | Acetylation | DQPGDPLKRSSFIIY CCCCCCCCCCHHHHH | 56.47 | 25953088 | |
| 406 | Phosphorylation | ELMGKRFSPKDPDDD HHCCCCCCCCCCCCC | 34.76 | 24719451 | |
| 408 | Succinylation | MGKRFSPKDPDDDKF CCCCCCCCCCCCCHH | 79.35 | 23954790 | |
| 433 | Phosphorylation | LRDLELAYQVHGLLK HHHHHHHHHHCCHHH | 24.56 | - | |
| 551 | Glutathionylation | LQVAFADCAADIKSA HHHHHHHHHHHHHHH | 2.78 | 22555962 | |
| 557 | Phosphorylation | DCAADIKSAYESQPI HHHHHHHHHHHCCCH | 36.10 | 28152594 | |
| 559 | Phosphorylation | AADIKSAYESQPIRQ HHHHHHHHHCCCHHH | 24.17 | 28152594 | |
| 561 | Phosphorylation | DIKSAYESQPIRQTA HHHHHHHCCCHHHHC | 28.69 | 28152594 | |
| 604 | Ubiquitination | GLFRKHNKIPRSELL HHHHHCCCCCHHHHH | 54.53 | 24816145 | |
| 650 | Sulfoxidation | EGLTQRVMSDFAINQ CCHHHHHHHHHCCCH | 3.29 | 21406390 | |
| 651 | Phosphorylation | GLTQRVMSDFAINQE CHHHHHHHHHCCCHH | 27.07 | 29449344 | |
| 664 | Phosphorylation | QEQKEALSNLTALTS HHHHHHHHHHHHHCC | 36.52 | 23186163 | |
| 667 | Phosphorylation | KEALSNLTALTSDSD HHHHHHHHHHCCCCC | 24.70 | 30108239 | |
| 670 | Phosphorylation | LSNLTALTSDSDTDS HHHHHHHCCCCCCCC | 28.20 | 25627689 | |
| 671 | Phosphorylation | SNLTALTSDSDTDSS HHHHHHCCCCCCCCC | 35.65 | 26657352 | |
| 673 | Phosphorylation | LTALTSDSDTDSSSD HHHHCCCCCCCCCCC | 42.02 | 25627689 | |
| 675 | Phosphorylation | ALTSDSDTDSSSDSD HHCCCCCCCCCCCCC | 41.55 | 25262027 | |
| 677 | Phosphorylation | TSDSDTDSSSDSDSD CCCCCCCCCCCCCCC | 33.56 | 30108239 | |
| 678 | Phosphorylation | SDSDTDSSSDSDSDT CCCCCCCCCCCCCCC | 40.76 | 30108239 | |
| 679 | Phosphorylation | DSDTDSSSDSDSDTS CCCCCCCCCCCCCCC | 45.12 | 30278072 | |
| 681 | Phosphorylation | DTDSSSDSDSDTSEG CCCCCCCCCCCCCCC | 40.75 | 30278072 | |
| 683 | Phosphorylation | DSSSDSDSDTSEGK- CCCCCCCCCCCCCC- | 46.90 | 30576142 | |
| 685 | Phosphorylation | SSDSDSDTSEGK--- CCCCCCCCCCCC--- | 32.41 | 30108239 | |
| 686 | Phosphorylation | SDSDSDTSEGK---- CCCCCCCCCCC---- | 49.71 | 30108239 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PTCD3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTCD3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTCD3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RT15_HUMAN | MRPS15 | physical | 19427859 | |
| RT29_HUMAN | DAP3 | physical | 26344197 | |
| RT18B_HUMAN | MRPS18B | physical | 26344197 | |
| RT23_HUMAN | MRPS23 | physical | 26344197 | |
| RT28_HUMAN | MRPS28 | physical | 26344197 | |
| RT35_HUMAN | MRPS35 | physical | 26344197 | |
| RT09_HUMAN | MRPS9 | physical | 26344197 | |
| BIRC7_HUMAN | BIRC7 | physical | 21516116 | |
| TBD2B_HUMAN | TBC1D2B | physical | 28514442 | |
| RBM38_HUMAN | RBM38 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-126, AND MASS SPECTROMETRY. | |